Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Amy Ogilvie to Disease Progression

This is a "connection" page, showing publications Amy Ogilvie has written about Disease Progression.

 
Connection Strength
 
 
 
0.394
 
  1. Ogilvie AC, Carnahan RM, Chrischilles EA, Schultz JL. The effects of antidepressants on depressive symptoms in manifest Huntington's disease. J Psychosom Res. 2022 11; 162:111023.
    View in: PubMed
    Score: 0.127
  2. Ogilvie AC, Nopoulos PC, Schultz JL. Sleep disturbances by disease type and stage in Huntington's disease. Parkinsonism Relat Disord. 2021 10; 91:13-18.
    View in: PubMed
    Score: 0.119
  3. Ogilvie AC, Nopoulos PC, Schultz JL. Quantifying the Onset of Unintended Weight Loss in Huntington's Disease: A Retrospective Analysis of Enroll-HD. J Huntingtons Dis. 2021; 10(4):485-492.
    View in: PubMed
    Score: 0.113
  4. Nopoulos S, Reasoner EE, Ogilvie AC, Killoran A, Schultz JL. Evaluating motor progression of juvenile-onset Huntington's Disease: An Enroll-HD analysis. Parkinsonism Relat Disord. 2024 Feb; 119:105954.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)